Dr. Vaithilingaraja Arumugaswami (left) and Dr. Song Li (right), UCLA Today the governing Board of the California Institute for Regenerative Medicine (CIRM) approved two additional projects as part of the $5 million in emergency funding for COVID-19 related projects. This brings the number of projects CIRM is supporting to 11, including two clinical trials. The Board awarded $349,999 … Continue reading CIRM Board Approves Two Additional COVID-19 Projects
UCLA
Two UCLA scientists receive CIRM funding for discovery research for COVID-19
Dr. Brigitte Gomperts (left) and Dr. Gay Crooks (right), UCLAImage Credit: UCLA Broad Stem Cell Center This past Friday, the CIRM Board approved funding for its first clinical study for COVID-19. In addition to this, the Board also approved two discovery stage research projects, which support promising new technologies that could be translated to enable … Continue reading Two UCLA scientists receive CIRM funding for discovery research for COVID-19
CIRM Board Funds its First Clinical Study for COVID-19
Dr. John Zaia, City of hope Today the governing Board of the California Institute for Regenerative Medicine (CIRM) continued its commitment to help with the coronavirus pandemic by awarding $749,999 to Dr. John Zaia at City of Hope. He will be conducting a clinical study to administer blood plasma from recovered COVID-19 patients to treat … Continue reading CIRM Board Funds its First Clinical Study for COVID-19
How quitting smoking helps your lungs regenerate; a discovery could lead to new ways to repair damaged lungs; and encouraging news in a stroke recovery trial
Photo courtesy Lindsay Fox Smoking is one of the leading causes of preventable death not just in the US, but worldwide. According to the US Centers for Disease Control and Prevention tobacco causes an estimated seven million deaths around the world, every single year. And for every person who dies, another 30 live with a … Continue reading How quitting smoking helps your lungs regenerate; a discovery could lead to new ways to repair damaged lungs; and encouraging news in a stroke recovery trial
CIRM supported study finds that a gene associated with autism influences brain stem cells
Dr. Bennett Novitch, UCLA Broad Stem Cell Research CenterImage Credit: UCLA Broad Stem Cell Research Center In a previous blog post, we discussed new findings in a CIRM supported study at the Salk Institute for Autism Spectrum Disorder (ASD), a developmental disorder that comes in broad ranges and primarily affects communication and behavior. This week, … Continue reading CIRM supported study finds that a gene associated with autism influences brain stem cells
CIRM Board Awards $15.8 Million to Four Translational Research Projects
Last week, the CIRM Board approved $32.92 million in awards directed towards four new clinical trials in vision related diseases and Parkinson's Disease. In addition to these awards, the Board also approved investing $15.80 million in four awards in the Translational Research program. The goal of this program is to help promising projects complete the … Continue reading CIRM Board Awards $15.8 Million to Four Translational Research Projects
Stem Cell Agency Approves Funding for Clinical Trials Targeting Parkinson’s Disease and Blindness
The governing Board of the California Institute for Regenerative Medicine (CIRM) yesterday invested $32.92 million to fund the Stem Cell Agency’s first clinical trial in Parkinson’s disease (PD), and to support three clinical trials targeting different forms of vision loss. This brings the total number of clinical trials funded by CIRM to 60. The PD … Continue reading Stem Cell Agency Approves Funding for Clinical Trials Targeting Parkinson’s Disease and Blindness
CIRM funded research could lead to treatment to prevent recurrence of deadly blood cancer
Chronic myelogenous leukemia Chronic myelogenous leukemia (CML) is a cancer of the white blood cells. It causes them to increase in number, crowd out other blood cells, leading to anemia, infection or heavy bleeding. Up until the early 2000’s the main weapon against CML was chemotherapy, but the introduction of drugs called tyrosine kinase inhibitors … Continue reading CIRM funded research could lead to treatment to prevent recurrence of deadly blood cancer
Engineered T cells made from stem cells could provide immunity against multiple cancers
Dr. Lily Yang Within all of our bodies there is a special type of "super" immune cell that holds enormous potential. Unlike regular immune cells that can only attack one cancer at a time, these "super" immune cells have the ability to target many types of cancers at once. These specialized cells are known as … Continue reading Engineered T cells made from stem cells could provide immunity against multiple cancers
Mind altering, life changing experience in stem cell lab
This week we are featuring the best blogs from our SPARK (Summer Program to Accelerate Regenerative medicine Knowledge) students. SPARK gives high school students a chance to spend their summer working in a world class stem cell research facility here in California. In return they write about their experiences and what they learned. The blog … Continue reading Mind altering, life changing experience in stem cell lab
The Stem Cellar 